Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cadent Therapeutics

Request full access

Cadent Therapeutics is a precision neuroscience company

Cambridge, United StatesFounded 2010Biotech & Life Sciences

About Cadent Therapeutics

Cadent Therapeutics is a biopharmaceutical company focused on developing first-in-class allosteric modulators to address unmet needs in central nervous system (CNS) disorders, including cognitive and movement disorders. The company leverages its extensive industry experience in medicinal chemistry, target selection, drug discovery, and drug optimization to advance a pipeline of novel allosteric modulators of ion channels. These ion channels, such as SK channels and NMDA receptors, are crucial for modulating neuronal communication and integration within the CNS. Cadent Therapeutics aims to positively modulate NMDA receptors to reverse hypofunction in schizophrenia patients and restore cognitive balance. Additionally, the company is developing positive allosteric modulators (PAMs) of SK channels to treat essential tremor (ET) and spinocerebellar ataxia (SCA). By targeting specific patient subsets based on genetics or other factors, Cadent Therapeutics strives to identify patients who will benefit most from their treatments, ensuring optimal efficacy with minimal side effects. The company operates in the biopharmaceutical market, serving patients with CNS disorders and generating revenue through the development and commercialization of its therapeutic candidates.

Source: Dealroom company data

At a glance

Status
Acquired
Open positions
None listed
Dealroom signal
24.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Neurology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Dec 2020 $770M $770M Novartis —
SERIES BOther financing Apr 2020 $15M $60M Access Industries · Qiming Venture Partners · Cowen Group · Clal Biotechnology Industries ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cadent Therapeutics website traffic

Latest recorded traffic for Cadent Therapeutics is 3.4K monthly website visits, up 353.3% over the last three months.

Latest monthly visits3.4K 3-month web change+353.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cadent Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Cadent Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Other known investors1 additional known investor

  • Novartis
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cadent Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cadent Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.